Descriptor English: | Fluticasone-Salmeterol Drug Combination | ||||||
Descriptor Spanish: |
Combinación Fluticasona-Salmeterol
| ||||||
Descriptor Portuguese: | Combinação Fluticasona-Salmeterol | ||||||
Descriptor French: | Association de fluticasone et de salmétérol | ||||||
Entry term(s): |
Advair Advair Diskus Advair HFA Combination, Fluticasone-Salmeterol Drug Combination, Fluticasone-Salmeterol Fluticasone - Salmeterol Fluticasone Propionate - Salmeterol Fluticasone Propionate - Salmeterol Combination Fluticasone Propionate - Salmeterol Xinafoate Fluticasone Propionate Salmeterol Fluticasone Propionate Salmeterol Combination Fluticasone Propionate Salmeterol Drug Combination Fluticasone Propionate Salmeterol Xinafoate Fluticasone Propionate Salmeterol Xinafoate Combination Fluticasone Propionate Salmeterol Xinafoate Drug Combination Fluticasone Propionate, Salmeterol Xinafoate Drug Combination Fluticasone Propionate-Salmeterol Drug Combination Fluticasone Propionate-Salmeterol Xinafoate Combination Fluticasone Propionate-Salmeterol Xinafoate Drug Combination Fluticasone Salmeterol Fluticasone Salmeterol Combination Fluticasone Salmeterol Drug Combination Fluticasone-Salmeterol Combination Seretide |
||||||
Tree number(s): |
D02.033.100.291.057.750.500 D02.092.063.291.057.750.500 D02.092.471.683.061.750.500 D04.210.500.054.079.129.114.500 D26.310.438 |
||||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D000068297 | ||||||
Scope note: | A drug combination of fluticasone and salmeterol that is used as an inhaler formulation to manage the symptoms of ASTHMA and CHRONIC OBSTRUCTIVE PULMONARY DISEASE. |
||||||
Allowable Qualifiers: |
AA analogs & derivatives AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis EC economics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine |
||||||
Pharm Action: |
Bronchodilator Agents Glucocorticoids Sympathomimetics |
||||||
Public MeSH Note: | 2016; FLUTICASONE PROPRIONATE-SALMETEROL XINAFOATE DRUG COMBINATION was indexed under ALBUTEROL 2001-2015; and under ANDROSTADIENES 2001-2015. |
||||||
History Note: | 2016 (2001) |
||||||
DeCS ID: | 55859 | ||||||
Unique ID: | D000068297 | ||||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
Date Established: | 2016/01/01 | ||||||
Date of Entry: | 2015/07/01 | ||||||
Revision Date: | 2017/01/17 |
-
-
CHEMICALS AND DRUGS
Organic Chemicals [D02]Organic Chemicals -
CHEMICALS AND DRUGS
Organic Chemicals [D02]Organic Chemicals -
CHEMICALS AND DRUGS
Organic Chemicals [D02]Organic Chemicals -
CHEMICALS AND DRUGS
Polycyclic Compounds [D04]Polycyclic Compounds -
CHEMICALS AND DRUGS
Pharmaceutical Preparations [D26]Pharmaceutical Preparations
|
Fluticasone-Salmeterol Drug Combination
- Preferred
Fluticasone Propionate, Salmeterol Xinafoate Drug Combination
- Narrower
Advair Diskus
- Narrower
Seretide
- Narrower
Advair HFA
- Narrower
Advair
- Narrower
Concept UI |
M000623538 |
Scope note | A drug combination of fluticasone and salmeterol that is used as an inhaler formulation to manage the symptoms of ASTHMA and CHRONIC OBSTRUCTIVE PULMONARY DISEASE. |
Preferred term | Fluticasone-Salmeterol Drug Combination |
Entry term(s) |
Combination, Fluticasone-Salmeterol Drug Combination, Fluticasone-Salmeterol Fluticasone - Salmeterol Fluticasone Salmeterol Fluticasone Salmeterol Combination Fluticasone Salmeterol Drug Combination Fluticasone-Salmeterol Combination |
Concept UI |
M000602345 |
Preferred term | Fluticasone Propionate, Salmeterol Xinafoate Drug Combination |
Entry term(s) |
Fluticasone Propionate - Salmeterol Fluticasone Propionate - Salmeterol Combination Fluticasone Propionate - Salmeterol Xinafoate Fluticasone Propionate Salmeterol Fluticasone Propionate Salmeterol Combination Fluticasone Propionate Salmeterol Drug Combination Fluticasone Propionate Salmeterol Xinafoate Fluticasone Propionate Salmeterol Xinafoate Combination Fluticasone Propionate Salmeterol Xinafoate Drug Combination Fluticasone Propionate-Salmeterol Drug Combination Fluticasone Propionate-Salmeterol Xinafoate Combination Fluticasone Propionate-Salmeterol Xinafoate Drug Combination |
Concept UI |
M000602351 |
Scope note | A dry powdered inhaler formulation of fluticasone-salmeterol drug combination. |
Preferred term | Advair Diskus |
Concept UI |
M0413150 |
Preferred term | Seretide |
Concept UI |
M000602353 |
Scope note | A metered dose inhaler formulation of fluticasone-salmeterol drug combination. |
Preferred term | Advair HFA |
Concept UI |
M000603319 |
Preferred term | Advair |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey